Connors Investor Services’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,403
Closed -$216K 157
2025
Q1
$216K Buy
14,403
+2,843
+25% +$47.3K 0.02% 135
2024
Q4
$190K Buy
11,560
+861
+8% +$17K 0.02% 147
2024
Q3
$264K Hold
10,699
0.03% 128
2024
Q2
$271K Hold
10,699
0.03% 124
2024
Q1
$272K Hold
10,699
0.03% 127
2023
Q4
$242K Hold
10,699
0.03% 127
2023
Q3
$199K Buy
10,699
+2,500
+30% +$51.8K 0.02% 137
2023
Q2
$213K Hold
8,199
0.02% 143
2023
Q1
$235K Hold
8,199
0.03% 139
2022
Q4
$243K Buy
+8,199
New +$233K 0.03% 130
2022
Q1
Sell
-7,699
Closed -$276K 162
2021
Q4
$276K Buy
7,699
+1,500
+24% +$60K 0.03% 131
2021
Q3
$264K Hold
6,199
0.03% 137
2021
Q2
$268K Buy
6,199
+500
+9% +$21.3K 0.03% 137
2021
Q1
$232K Buy
5,699
+1,000
+21% +$37.9K 0.03% 141
2020
Q4
$213K Buy
+4,699
New +$178K 0.03% 131

Other funds holding ANIK